We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BIOBASE

The BIOBASE Group focuses on the development, production and management of scientific equipment, in vitro diagnosis (... read more Featured Products: More products

Download Mobile App





BIOBASE Showcases Comprehensive Range of Laboratory Solutions

By LabMedica International staff writers
Posted on 06 Feb 2025

BIOBASE (Shandong, China) is presenting its most popular laboratory products at Medlab Middle East 2025, including clinical chemistry, electrolyte and immunoassay analyzers.

The BK-410 automatic chemistry analyzer featured at the event is engineered to streamline laboratory workflows, providing reliable and precise results with unparalleled speed. Its comprehensive feature set makes it an invaluable asset for high-volume testing environments, ensuring accurate diagnostics and efficient laboratory operations. Featured alongside is the BKI1100 automatic chemiluminescence immunoassay system which uses magnetic particle separation technology for faster reaction speed and higher efficiency. BIOBASE is demonstrating the BK-EL10C ELISA microplate reader which uses enzyme-linked immunosorbent assay (ELISA) and other experimental methods to measure the absorbance and fluorescence intensity of reactants to quantitatively analyze specific components in samples.

BIOBASE is also showcasing the BKE-B electrolyte analyzer which adopts advanced ion-selective electrode measurement technology and is a fast, accurate, convenient, and practical clinical testing instrument. It can directly measure the concentration of K+, Na+, Cl-, Ca2+, and pH in serum, plasma, whole blood, cerebrospinal fluid, and diluted urine. In addition, BIOBASE is demonstrating the BKP2000 multi-channel dry fluorescence immunoassay analyzer with 12 independent incubation channels. The instrument comprises an optical detection module (fluorescence), scanning module, data processing module, liquid crystal display module, incubation module, information acquisition module (ID card reader), power supply, and printer. It also features automatic induction of reagent card insertion, automatic printing of test results, and automatic card loss along with a 10.1-inch LCD screen for a better visual experience.

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
New
Respiratory QC Panel
Assayed Respiratory Control Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.